HOME >> MEDICINE >> NEWS
Trials launched to test treatment of cognitive dysfunction in schizophrenia

The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS). The research will test the effectiveness of new drug treatments for the cognitive deficits of schizophrenia. The project will be directed by Stephen R. Marder, M.D., at UCLA with investigators at Harvard's Massachusetts General Hospital, Boston, the University of North Carolina, Chapel Hill, the University of Maryland, Baltimore, Duke University, Durham, Washington University, St. Louis, and Nathan Kline Institute for Psychiatric Research, New York.

Schizophrenia is a chronic, severe, and disabling brain disease. Approximately 1 percent of the population develops schizophrenia during their lifetime -- more than 2 million Americans suffer from the illness in a given year. Although available medications are reasonably effective in treating the positive symptoms of the illness such as hallucinations and delusions, recent research indicates that cognitive impairments in areas such as attention, memory and problem solving are responsible for much of the disability associated with the disease.

"Unfortunately, the medications currently available do little to remedy this aspect of the illness. Consequently, many patients have serious residual symptoms and only one in five are able to recover sufficiently to work," said Thomas R. Insel, M.D., director of NIMH.

The NIMH approach is built on the assumption that progress in developing new treatments will require collaboration between the best academic, government and industry scientists. The TURNS is one component of a multipronged NIMH effort to stimulate academic and industry sponsored research focused on cognitive deficits in schizophrenia. It follows completion of the Measuremen
'"/>

Contact: Jennifer Loukissas
nimhpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health
5-May-2004


Page: 1 2

Related medicine news :

1. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
2. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
3. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
4. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
5. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
6. Mayo Clinic Study Finds Costs For Cancer Clinical Trials Comparable To Costs For Standard Treatment
7. Retrospective Statistical Analysis Corroborates Early Results Of Randomized Breast Cancer Trials
8. Scientific Trials Of So-Called Wonder Hormone Treatment For Autism Will Be Conducted In Seattle, Denver
9. Clinical Trials Announced Using Non-Invasive Innovative MRI To Diagnose Breast Tumors
10. History In The Making: The Discovery And Clinical Trials Of Viagra
11. OHSU Scientists Begin Human Trials Of A Drug Aimed At The Underlying Cause Of Chronic Myelogenous Leukemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... 2020 , ... A new study completed by Xavier University ... a 59 percent decrease in hospital onset CDI. This is double the recent ... , The retrospective pre-post [study recently published in The Journal of ...
(Date:1/24/2020)... ... 2020 , ... dicentra , a leading Contract Research ... is pleased to announce that Dr. Homa Assadi has joined as Clinical Research ... Canada. , Dr. Assadi’s extensive experience pertains to research protocol development, statistical design, ...
(Date:1/23/2020)... YORK (PRWEB) , ... January 23, 2020 , ... ... leader in medical and scientific training, biomedical research, and patient care—today announced the ... the Office of Gender Equity in Science and Medicine. The awards aim to ...
(Date:1/23/2020)... ... 2020 , ... SignatureCare Emergency Center is set to expand to North Dallas ... Located in the heart of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, ... support staff. , It will serve residents and businesses around Lewisville, TX, including ...
(Date:1/23/2020)... ... January 23, 2020 , ... DelawareBio, ... life-science industry, presents a panel discussion on gene editing that goes beyond CRISPR ... H. Ammon Medical Education Center, the event will provide an overview of the ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... ... January 12, 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, ... Takeda Ventures, Inc, operating under a tender from the Israeli Innovation Authority (IIA) ... Ramot at Tel-Aviv University and Glasgow University. , Epeius pharma develops next ...
(Date:1/10/2020)... CITY, Pa. (PRWEB) , ... January 10, 2020 ... ... Center (GCMC) have finalized an affiliation agreement that officially brings GCMC into the ... The newly-branded AHN Grove City provides the network and its patients with a ...
(Date:1/10/2020)... ... 10, 2020 , ... Representatives with MyBioGate announced that they are organizing the ... conference will be held on 12 January 2020 at the Grand Hyatt San Francisco ... gateway to China’s healthcare and life science industry. For the overseas biopharmas interested in ...
Breaking Medicine Technology:
Cached News: